Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2025 of 5804
-
Could a new MRI scan spot prostate cancer better?
Diagnosis Recruiting nowThe goal of this multi-center clinical study is to evaluate whether time-dependent diffusion MRI (TDDMRI) can provide reliable microstructural imaging markers for the diagnosis of prostate cancer. The main questions this study aims to answer are: * Do TDDMRI-derived microstructu…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Shoulder surgery showdown: which replacement works best?
Disease control Recruiting nowThere are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized st…
Phase: NA • Sponsor: La Tour Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a rheumatoid arthritis drug tame immunotherapy side effects?
Disease control OngoingThe goal of this clinical trial is to compare the safety and effectiveness of infliximab compared to steroids for the treatment of immune checkpoint inhibitor-induced colitis (ICI colitis) in patients with stage III/IV skin cancer. The main questions this study aims to answer ar…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a pill stop sleep disorder from turning into Parkinson's?
Disease control Ongoing142 cases of patients with iRBD will be recruited from the neurology department of Ruijin Hospital, th second Affiliated Hospital of Soochow University and wuhan Union Hospital. After the informed consent was signed, they were divided into a trial group and a control group random…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study aims to uncover hidden risks of kidney disease in american indians
Knowledge-focused Recruiting nowDespite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in …
Sponsor: University of New Mexico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could an epilepsy drug ease stubborn psychosis?
Symptom relief CompletedThis is a 12-week study of levetiracetam added to a second generation antipsychotic in early psychosis patients who have been ill for less than 5 years and continue to experience psychotic symptoms despite at least 8 weeks of antipsychotic treatment. Levetiracetam (Keppra) is a m…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New HIV prevention pill shows promise in Real-World study
Prevention CompletedSubjects who go to emergency room for possible contact to HIV transmission receive Delstrigo as post exposition prophylaxis.
Phase: PHASE4 • Sponsor: Hospital Clinic of Barcelona • Aim: Prevention
Last updated Jun 26, 2026 15:48 UTC
-
New PET tracer could spot hidden cancers
Diagnosis OngoingThis exploratory study investigates how an imaging technique called 68Ga-FAPi-46 PET/CT can determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues in patients with cancer. Because some cancers take up 68Ga-FAPi-46 it can be see…
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Sickle cell gene therapy trial halted after just 4 patients
Disease control TerminatedThis study evaluated a genome-edited, autologous, hematopoietic stem and progenitor cell (HSPC) product - OTQ923 to reduce the biologic activity of BCL11A, increasing fetal hemoglobin (HbF) and reducing complications of sickle cell disease.
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Deeper DNA analysis may unlock better cancer care
Knowledge-focused Recruiting nowThe "simple" analysis of the exome can determine somatic and constitutional mutations. The major challenge lies in the translation of sequencing data into clinically relevant information allowing the clinician to guide his decision-making A "complex" analysis of the exome would p…
Phase: PHASE2 • Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Bone loss after bariatric surgery: could denosumab be the answer?
Disease control CompletedBariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for celiac sufferers: drug targets stubborn symptoms
Symptom relief CompletedThis study will evaluate the efficacy and safety of PRV-015 in adult patients with non-responsive celiac disease (NRCD) who are on a gluten-free diet (GFD).
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo shows promise for rare autoimmune disease
Disease control CompletedThis is a Phase 2a, multi-center, open-label, two-arm study of approximately 25 patients with active IgG4-related disease (IgG4-RD). The two arms include (1) Experimental: rilzabrutinib with glucocorticoids and (2) Active Comparator: glucocorticoids only.
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Acupuncture needles may unlock relief for stubborn neck pain
Symptom relief CompletedThe goal of this clinical trial is to determine whether acupuncture can improve neck pain and shoulder movement in people with chronic neck pain. Researchers will compare acupuncture with sham acupuncture (a procedure designed to resemble acupuncture without therapeutic effects) …
Phase: NA • Sponsor: Hualien Tzu Chi General Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Stroke speech therapy: finding the right dose
Symptom relief CompletedAfter a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Sp…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Could a muscle relaxant stop deadly heart rhythms?
Disease control CompletedThis is a randomized, placebo-controlled trial of Dantrolene (N= 84 participants) to demonstrate the feasibility of using intravenous (IV) dantrolene to study the effect of RyR2 inhibition on cardiac electrophysiology, hemodynamics, and ventricular arrhythmia inducibility in pati…
Phase: PHASE2, PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New program aims to get more people screened for colon cancer in appalachia
Prevention CompletedThis project aims to implement a multi-level group randomized trial, delayed intervention that includes components targeting clinics, providers, patients, and the community to increase colorectal cancer (CRC) screening, follow-up, and referral-to-care among patients age 50-74 in …
Phase: NA • Sponsor: University of Kentucky • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
COVID-19 drug trial halted: LAU-7b studied in hospitalized patients
Disease control TerminatedA randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.
Phase: PHASE2, PHASE3 • Sponsor: Laurent Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a zapping cap help Alzheimer's patients remember?
Symptom relief OngoingAlzheimer's disease (AD) is the leading neurodegenerative disease of aging characterized by multiple cognitive impairments. Given the recent failures of disease-modifying drugs, the current focus is on preventing or mitigating synaptic damage that correlates with cognitive declin…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New Self-Test could revolutionize cervical cancer screening
Diagnosis CompletedCervical cancer is primarily caused by Human Papillomaviruses (HPV). Testing for HPV in cervical samples is now an option for cervical cancer screening. HPV can also be tested from self-collected samples which may help to improve access to screening, since it does not require a d…
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC